Skip to main content
. 2025 Jun 19;14(6):3359–3372. doi: 10.21037/tcr-2024-2539

Figure 5.

Figure 5

Analysis of plasma IL-32 levels stratified by lymph node metastasis status and leukocyte level. (A) Plasma IL-32 concentrations in HNSCC patients with and without LNM. (B) IL-32 concentrations in high and low leukocyte subgroups. (C,D) Comparative leukocyte profiles between patients with and without LNM. HNSCC, head and neck squamous cell carcinoma; IL-32, interleukin-32; LNM, lymph node metastasis; ns, not significant.